BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36467079)

  • 1. Integrated analysis of comprehensive metabolomics and network pharmacology to reveal the mechanisms of
    Liao JC; Li CY; Teng FM; Jian-Chen ; Yu JY; Ju WZ; Zou JD
    Front Pharmacol; 2022; 13():1064498. PubMed ID: 36467079
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of
    Gu L; Hong F; Fan K; Zhao L; Zhang C; Yu B; Chai C
    Drug Des Devel Ther; 2020; 14():4053-4067. PubMed ID: 33061308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
    Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
    Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergic renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced chronic kidney disease rats based on integrated plasma metabolomics and network pharmacology approach.
    Zhang ZM; Yang L; Wan Y; Jiang S; Shang EX; Qian DW; Duan JA
    Life Sci; 2021 Aug; 278():119545. PubMed ID: 33930370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated network pharmacology, transcriptomics, and metabolomics analysis to reveal the mechanism of salt Eucommiae cortex in the treatment of chronic kidney disease mineral bone disorders via the PPARG/AMPK signaling pathway.
    Shen J; Liu Y; Wang Q; Chen H; Hu Y; Guo X; Liu X; Li Y
    J Ethnopharmacol; 2023 Oct; 314():116590. PubMed ID: 37207881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive Compounds from
    Hou J; Qian J; Li Z; Gong A; Zhong S; Qiao L; Qian S; Zhang Y; Dou R; Li R; Yang Y; Gu C
    Onco Targets Ther; 2020; 13():959-973. PubMed ID: 32099399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Wogonoside in acute myocardial ischemia rats.
    Feng W; Duan C; Pan F; Yan C; Dong H; Wang X; Zhang J
    J Ethnopharmacol; 2023 Dec; 317():116871. PubMed ID: 37393028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of
    Xu Z; Qian L; Niu R; Wang Y; Yang Y; Liu C; Lin X
    Front Nephrol; 2022; 2():834513. PubMed ID: 37675022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the potential mechanism of Qingxin Lianzi Yin Decoction on renoprotection in db/db mice via network pharmacology and metabolomics.
    Gao WY; Tian MY; Li ML; Gao SR; Wei XL; Gao C; Zhou YY; Li T; Wang HJ; Bian BL; Si N; Zhao W; Zhao HY
    Phytomedicine; 2024 Apr; 126():155222. PubMed ID: 38382279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of in vivo metabolic profile of Abelmoschus Manihot based on pattern recognition analysis.
    Guo JM; Lin P; Lu YW; Duan JA; Shang EX; Qian DW; Tang YP
    J Ethnopharmacol; 2013 Jun; 148(1):297-304. PubMed ID: 23632309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolomics reveals the therapeutic effect of HuangQi Injections in cisplatin-induced nephrotoxic rats.
    Li CY; Song HT; Wang XX; Wan YY; Ding XS; Liu SJ; Dai GL; Liu YH; Ju WZ
    Sci Rep; 2017 Jun; 7(1):3619. PubMed ID: 28620200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-β/Smad signaling pathway.
    Cai H; Wang J; Luo Y; Wang F; He G; Zhou G; Peng X
    Biomed Pharmacother; 2021 Feb; 134():111098. PubMed ID: 33341058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Brain Metabolomics and Network Pharmacology Analysis to Reveal the Improvement Effect of Bai Chan Ting on Parkinson's Disease.
    Zhang N; Fu J; Gao X; Lu F; Lu Y; Liu S
    Biomed Res Int; 2022; 2022():6113093. PubMed ID: 36523484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protective effect and action mechanism of Huangkui capsule and its main five flavonoids.
    Cai HD; Su SL; Qian DW; Guo S; Tao WW; Cong XD; Tang R; Duan JA
    J Ethnopharmacol; 2017 Jul; 206():152-159. PubMed ID: 28408246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad range metabolomics coupled with network analysis for explaining possible mechanisms of Er-Zhi-Wan in treating liver-kidney Yin deficiency syndrome of Traditional Chinese medicine.
    Zhai Y; Xu J; Feng L; Liu Q; Yao W; Li H; Cao Y; Cheng F; Bao B; Zhang L
    J Ethnopharmacol; 2019 Apr; 234():57-66. PubMed ID: 30690072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis.
    Wu J; Luo Y; Shen Y; Hu Y; Zhu F; Wu J; Liu Y
    Drug Des Devel Ther; 2022; 16():3739-3776. PubMed ID: 36324421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.
    Zhang D; Liu B; Jie X; Deng J; Lu Z; Lu F; Liu X
    Front Pharmacol; 2021; 12():761572. PubMed ID: 34867380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite identification strategy of non-targeted metabolomics and its application for the identification of components in Chinese multicomponent medicine Abelmoschus manihot L.
    Guo JM; Lu YW; Shang EX; Li T; Liu Y; Duan JA; Qian DW; Tang YP
    Phytomedicine; 2015 May; 22(5):579-87. PubMed ID: 25981925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.